Bank of New York Mellon’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-23,518
Closed -$23K 4382
2019
Q1
$23K Sell
23,518
-644
-3% -$691 ﹤0.01% 4156
2018
Q4
$20K Sell
24,162
-10,000
-29% -$19.7K ﹤0.01% 4160
2018
Q3
$95K Buy
34,162
+10,000
+41% +$28.5K ﹤0.01% 4050
2018
Q2
$68K Sell
24,162
-12,728
-35% -$37.8K ﹤0.01% 4056
2018
Q1
$74K Buy
36,890
+13,234
+56% +$28.7K ﹤0.01% 4108
2017
Q4
$54K Buy
23,656
+6,156
+35% +$13.4K ﹤0.01% 4197
2017
Q3
$38K Sell
17,500
-15
-0.1% -$31 ﹤0.01% 4146
2017
Q2
$39K Buy
17,515
+15
+0.1% +$37 ﹤0.01% 4167
2017
Q1
$50K Hold
17,500
﹤0.01% 4140
2016
Q4
$49K Sell
17,500
-2,308
-12% -$6.54K ﹤0.01% 4134
2016
Q3
$61K Buy
19,808
+942
+5% +$3.54K ﹤0.01% 4113
2016
Q2
$41K Buy
18,866
+1,366
+8% +$1.89K ﹤0.01% 4212
2016
Q1
$25K Hold
17,500
﹤0.01% 4162
2015
Q4
$31K Hold
17,500
﹤0.01% 4242
2015
Q3
$15K Hold
17,500
﹤0.01% 4338
2015
Q2
$14K Hold
17,500
﹤0.01% 4246
2015
Q1
$10K Hold
17,500
﹤0.01% 4217
2014
Q4
$9K Buy
17,500
+3,000
+21% +$6.96K ﹤0.01% 4234
2014
Q3
$42K Buy
14,500
+2,000
+16% +$5.63K ﹤0.01% 4159
2014
Q2
$28K Hold
12,500
﹤0.01% 4115
2014
Q1
$42K Buy
+12,500
New +$49K ﹤0.01% 4098

Other funds holding SPHS

Bank of New York Mellon's SPHS Position: Q2 2019 in Review

Bank of New York Mellon sold out of Sophiris Bio, Inc. (SPHS) in Q2 2019, closing a stake of 23,518 shares — an estimated $23K sold.

Bank of New York Mellon first reported a position in SPHS in Q1 2014 and held it in 21 quarters. The position peaked at $95K in Q3 2018. 22 funds tracked by Wall St. Rank hold SPHS as of Q2 2019.

  • Bank of New York Mellon reported no remaining Sophiris Bio, Inc. position as of Q2 2019 after selling out during the quarter.
  • Bank of New York Mellon sold 23,518 Sophiris Bio, Inc. shares in Q2 2019, an estimated $23K.
  • Bank of New York Mellon first reported a position in Sophiris Bio, Inc. in Q1 2014 and held it in 21 quarters.
  • Bank of New York Mellon's Sophiris Bio, Inc. position peaked at $95K in Q3 2018.
  • 22 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2019.

Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.